We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+38.21%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$108M
AUM Growth
–
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
87.56%
Top 10 Holdings %
Top 10 Hldgs %
39.31%
Holding
80
New
80
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Cytokinetics
CYTK
|
+$5.94M |
| 2 |
DRRX
DURECT Corp
DRRX
|
+$5.04M |
| 3 |
CLDR
Cloudera, Inc.
CLDR
|
+$4.58M |
| 4 |
Aviat Networks
AVNW
|
+$3.29M |
| 5 |
SFE
Safeguard Scientifics, Inc.
SFE
|
+$3.12M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 36.62% |
| 2 | Technology | 17.3% |
| 3 | Financials | 11.58% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Energy | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rigel Pharmaceuticals
RIGL
$758M
| $1.4M | 1.3% |
+40,000
| New | +$1.16M |
|
27
Bristow Group
VTOL
$1.29B
| $1.4M | 1.29% |
+53,000
| New | +$1.29M |
|
|
ENLC
28
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.3M | 1.2% |
+350,000
| New | +$1.15M |
|
|
FLNA
29
Filana Therapeutics
FLNA
$51.2M
| $1.19M | 1.11% |
+175,000
| New | +$1.56M |
|
30
First Financial Corp
THFF
$912M
| $1.09M | 1.01% |
+28,000
| New | +$1.02M |
|
31
Smith Micro Software
SMSI
$14.4M
| $1.08M | 1.01% |
+5,000
| New | +$951K |
|
32
Battalion Oil
BATL
$36.1M
| $1.08M | 1% |
+130,000
| New | +$976K |
|
33
Coherus Oncology
CHRS
$214M
| $1.04M | 0.97% |
+60,000
| New | +$1.07M |
|
34
CVS Health
CVS
$138B
| $1.02M | 0.95% |
+15,000
| New | +$976K |
|
35
VYNE Therapeutics
VYNE
$25.7M
| $1.02M | 0.94% |
+8,947
| New | +$1.12M |
|
36
Tejon Ranch
TRC
$500M
| $1.01M | 0.94% |
+70,000
| New | +$1.02M |
|
37
Cartesian Therapeutics
RNAC
$249M
| $985K | 0.91% |
+10,833
| New | +$939K |
|
|
BCEL
38
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $969K | 0.9% |
+60,000
| New | +$900K |
|
|
UFS
39
DELISTED
DOMTAR CORPORATION (New)
UFS
| $950K | 0.88% |
+30,000
| New | +$854K |
|
|
B
40
Barrick Mining
B
$58.5B
| $911K | 0.84% |
+40,000
| New | +$1.01M |
|
41
Warner Bros
WBD
$68.2B
| $903K | 0.84% |
+30,000
| New | +$736K |
|
42
Travere Therapeutics
TVTX
$5.23B
| $872K | 0.81% |
+32,000
| New | +$747K |
|
43
SandRidge Energy
SD
$504M
| $868K | 0.8% |
+280,000
| New | +$687K |
|
|
FLXN
44
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $866K | 0.8% |
+75,000
| New | +$872K |
|
45
Energy Transfer Partners
ET
$70.1B
| $865K | 0.8% |
+140,000
| New | +$847K |
|
|
SPPI
46
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $853K | 0.79% |
+250,000
| New | +$1.03M |
|
47
BioCardia
BCDA
$12.6M
| $796K | 0.74% |
+15,333
| New | +$612K |
|
|
ITCI
48
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $795K | 0.74% |
+25,000
| New | +$657K |
|
49
IAMGOLD
IAG
$8.21B
| $734K | 0.68% |
+200,000
| New | +$734K |
|
|
HGEN
50
DELISTED
HUMANIGEN, INC.
HGEN
| $700K | 0.65% |
+40,000
| New | +$479K |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM
CM Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for CM Management, which disclosed 80 positions worth $108M. Its ten largest holdings account for 39% of the portfolio.
Its largest position is Cytokinetics: 325,000 shares worth $6.75M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, followed by Technology and Financials.
- CM Management's largest Q4 2020 buy was Cytokinetics: 325,000 shares worth $6.75M.
- CM Management's ten largest holdings make up 39% of its $108M portfolio in Q4 2020.
- CM Management disclosed 80 positions in Q4 2020, its first 13F filing on record.
Based on CM Management's 13F filing for Q4 2020, filed 4 Feb 2021.